Selexis CHO Cells in Suspension-1

In the News

Read more about Selexis partnerships, technology and people featured in key media outlets.

2020

May 19, 2020

Contract Pharma Selexis Makes Scientific and Operational Promotions by Contract Pharma Staff

 

February 11, 2020

Genetic Engineering & Biotechnology News Selexis Cell Line Development Strategies by John Morrow, Jr., PhD

 

2019

September 21, 2019

The Center for Biosimilars First Dornase Alfa Biosimilar Approved and Launched in Russia by The Centers for Biosimilars Staff

 

April 11, 2019

Bipharma-Reporter.com Selexis’ biologic platform generates first-ever approved Soliris biosimilar by Maggie Lynch

 

April 11, 2019 

BioProcess International World’s first Soliris biosimilar launched in Russia by Dan Stanton

 

January 14, 2019

BioProcess International Selexis and Agenus expand immune-oncology cell line deal by BPI Staff

 

2018

December 27, 2018 

BioProcess International TeneoBio expands cell banking deal with Selexis by Dan Stanton

 

October 9, 2018

BioProcess International Hoba (cell) banks on Selexis to advance neuropathic pain program by Dan Stanton

 

July 11, 2018 

Biopharma-Reporter.com Selexis and Symphogen Expand Partnership to Process two mAbs by Ben Hargreaves

 

April 19, 2018 

BioPharma-Reporter.com Selexis Says $2M Investment Will Speed Up Cell Bank Delivery Time by Flora Southey

 

February 28, 2018

FierceBiotech Xencor extends collaboration with Selexis to advance bispecific antibody programs by Angus Liu

 

2017

November 1, 2017

Genetic Engineering News Weighing Protein Expression Levels with Cell Growth by Angelo DePalma, Ph.D.

 

June 27, 2017  BioProcess International Selexis Announces Commercial License Agreement with Takeda for the Development of Fusion Proteins by BPI Contributor

 

May 8, 2017 

Biopharma-Reporter.com Selexis’ Swiss Investment in mammalian cell lines by Flora Southey

 

February 21, 2017 

\BioPharma-Reporter.com Sanofi hires Selexis SA for three cell line development deals by Gareth Macdonald

 

2016

October 10, 2016

Contract Pharma Cell Line Development Trends: How CHO cell line development technologies are improving biologics development from early phase to IND By Igor Fisch

 

October 7, 2016

BioProcess International BioProcess International Announces Winners of the 2016 BioProcess International Awards by BPI Staff September 12, 2016 BioPharma-Reporter.com Selexis to triple cell line capacity on back of increased demand by Dan Stanton

 

April 18, 2016 

BioProcess International Cancer Immunotherapies: Fulfilling the Promise of Protein and Cell Therapies by Angelo DePalma

 

April 15, 2016

Genetic Engineering News GEN Roundup: How to Improve Cell-Line Productivity by GEN Staff Writer

 

2015

May 11, 2015

Genetic Engineering & Biotechnology News Ligand Buys Another 15 Biologics Programs from Selexis for $4M